CVNA Carvana Co

Previous close
$313.91
Est. 12 months change
+42.99%
Projected Price
$450.21

Profitability Metrics

Return on Equity (ROE)
68.42%
Return on Assets (ROA)
12.49%
Return on Invested Capital (ROIC)
29.02%
Weighted Average Cost of Capital (WACC)
24.49%
ROIC - WACC
4.53%
Updated : 2026-04-03 18:51 ET

Valuation Metrics

P/E Ratio
38.10
Forward P/E
43.04
PEG Ratio
-
Debt Current Ratio
4.31

Growth & Cash Flow

Gross Margin
20.63%
Operating Margin
9.27%
FCF Margin
4.37%
TTM Revenue Growth
57.96%
Projected 12M EPS Growth
-11.50%

Price Change

Price % from 50 SMA
-9.99%
Price % from 200 SMA
-13.73%
6 Months
-20.47%
1 Year
38.70%
2 Years
278.80%
Click here to see the list of ETFs containing CVNA as a top holding :Carvana Co ETFs

Analysis

Company Overview

Carvana operates an online used car marketplace enabling consumers to buy, sell, and finance vehicles entirely through a digital experience. Sector: Consumer Discretionary.

Overview

Carvana Co (CVNA) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

From a capital efficiency perspective, ROIC is 29.02%, WACC is 24.49%, and the economic spread is 4.53%. On balance, the company marginally exceed their cost of capital, suggesting modest but present value creation. Supporting metrics show ROE at 68.42% and ROA at 12.49%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that is value-creative but with less room for execution slippage.

Valuation

Multiple analysis puts the company at trailing P/E of 38.10, forward P/E of 43.04. Trailing and forward multiples are nearly identical, indicating the market is pricing the company on a relatively static earnings assumption. The current ratio of 4.31 indicates the company is well-positioned to meet near-term obligations. The combined valuation and liquidity profile points to a company where current prices embed meaningful growth expectations, and where delivery against those expectations will drive the return outcome.

Margins & Cash Generation

On the margin front: gross margin sits at 20.63%, operating margin at 9.27%, and free cash flow margin at 4.37%. At this level, gross margins suggest a more competitive or capital-intensive operating environment across the the company. The operating margin reading is below average, pointing to businesses where scaling costs remain a challenge. Weak free cash flow margins point to the company where near-term cash generation is constrained by investment or operational cash demands. The combined margin read is functional rather than exceptional, which can increase sensitivity to cost pressure or slower demand.

Growth & Forward Outlook

The two main inputs to the near-term picture — TTM revenue growth of 57.96% reflecting robust top-line expansion across the company. Consensus EPS estimates point to a decline of -11.5% over the next 12 months, adding a layer of risk to the forward case and warranting caution on the earnings trajectory. Analyst price targets suggest street expectations point to meaningful upside if execution holds on a 12-month view. Revenue momentum establishes the baseline; analyst price targets reveal how much the market is already paying for future execution on top of that baseline. Delivered returns will ultimately be shaped by the gap — or lack thereof — between operating execution and the expectations embedded in current prices. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The composite picture leans positive, with capital efficiency and growth momentum providing the core of the investment thesis.

The analysis above draws from quantitative data only and does not constitute personalized financial advice. Investors should conduct independent research and consider professional guidance before acting on any information presented here.